Search

Displaying results 9661 - 9670 of 10000 in total
  1. Drug

    AT3022

    go.drugbank.com/drugs/DB05172
    Experimental

    AT3022, the Altea Therapeutics’s fentanyl citrate transdermal patch designed to provide safe and rapid management of moderate to severe chronic pain.

  2. Drug

    Naluzotan

    go.drugbank.com/drugs/DB05562
    Investigational

  3. Drug

    TC-2696

    go.drugbank.com/drugs/DB05576
    Experimental

    Synonyms: 5-(5-METHOXY-3-PYRIDINYL)-N-METHYL-4-PENTEN-2-AMINE, (2S,4E)-
  4. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications. It is being developed by Vitae Pharmaceuticals.

  5. Drug

    ALKS 29

    go.drugbank.com/drugs/DB05723
    Experimental

    ALKS 29 is a new product candidate for the treatment of alcohol dependence. It is being developed by Alkermes, Inc.

  6. Drug

    AL-02

    go.drugbank.com/drugs/DB06065
    Experimental

  7. Drug

    TG1024

    go.drugbank.com/drugs/DB06180
    Experimental

  8. Drug

    NRP290

    go.drugbank.com/drugs/DB06383
    Experimental

    NRP290 is a hydrocodone derivative under investigation for the treatment of pain (moderate to moderately severe).

  9. Drug

    Dotarizine

    go.drugbank.com/drugs/DB06446
    Experimental

  10. Drug

    IR502

    go.drugbank.com/drugs/DB06463
    Experimental

    IR502 (Zorcell) is a potential treatment for psoriasis.